KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.32
Today's Change
+0.005 (1.59%)
Day's Change
0.315 - 0.32
Trading Volume
556,100
only half sen? dream higher la, I wish their business is good so we can get more dividend
3 weeks ago
still havent meet the criteria also, earliest also 2026 only can transfer to main board
2 weeks ago
Dr. Lee bought again. Strong support will be formed at 32 cents
https://klse.i3investor.com/web/insider/detail/D_183655_946568881
2 weeks ago
Indeed, excellent Q2 performance = good news. Feel free to peruse it 😊
https://klse.i3investor.com/web/blog/detail/NewLifeNewWay/2025-01-22-story-h497934750-Alpha_IVF_Reports_Yet_Another_Record_Q2_FY25_Financial_Results
2 weeks ago
Alpha IVF Group’s 2QFY5/25 net profit increased 23.6% YoY to RM15.1m thanks to higher sales revenue from foreign patients. Indonesian patients are Alpha IVF’s largest clientele, contributing about 34.9% to its total revenue while patients from China contributed 25.2%. Beyond China, Alpha IVF further expanded in the Southeast Asia region with the establishment of a full-fledged IVF centre in the Philippines and a first satellite clinic in Indonesia, tapping into these rapidly growing markets.
Sadly no dividend announced
2 weeks ago
Higher sales figures are mostly from foreign patients, good move for Alpha to keep expanding towards China and South East Asia.
1 week ago
Patients dr Indonesia paling byk. Rasa bilangan patient dr Filipina dan Cina juga akan bertmbah scr berdadah pd masa depan
1 week ago
it is undervalued indeed, even analyst forecast that the industry will continue to see decent growth yet the price of the share is not moving at all
1 week ago
The next few quarters should continue to see decent growth, on the back of increased patient volume from China following the launch of the sales representative office
https://www.thestar.com.my/business/business-news/2025/01/23/alpha-ivf-to-see-rising-customer-demand
1 week ago
Alpha said that 2Q25 continued to see a high foreign patient mix, in part due to maiden contribution from the SRO in Shanghai, China. A full quarter’s contribution from the China SRO and the establishment of a satellite clinic in Jakarta, Indonesia should support overall patient volume
1 week ago
even uob still maintaining their buy recommendation, means the current price really below its real value
1 week ago
Short term will get down to 28...it has broken 32 support. No other catalyst until next QR
1 week ago
I dnt think so because there will be another market expansion and it will rebound
5 days ago
Hopefully. Only time will tell. Recent Q earnings did not even move the stock by any means....
5 days ago
Alpha IVF is seeing more foreigners seeking for its in vitro fertilisation services in 2025 with the thriving health tourism sector
1 day ago
phunkietown
Good buy amy, now ride the ALPHA IVF train to 0.40
3 weeks ago